Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 25:14:95.
doi: 10.1186/1471-2369-14-95.

The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol

Stephanie Stringer  1 , Praveen Sharma, Mary Dutton, Mark Jesky, Khai Ng, Okdeep Kaur, Iain Chapple, Thomas Dietrich, Charles Ferro, Paul Cockwell
Affiliations

The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol

Stephanie Stringer et al. BMC Nephrol. .

Abstract

Background: Chronic kidney disease (CKD) affects up to 16% of the adult population and is associated with significant morbidity and mortality. People at highest risk from progressive CKD are defined by a sustained decline in estimated glomerular filtration rate (eGFR) and/or the presence of significant albuminuria/proteinuria and/or more advanced CKD. Accurate mapping of the bio-clinical determinants of this group will enable improved risk stratification and direct the development of better targeted management for people with CKD.

Methods/design: The Renal Impairment In Secondary Care study is a prospective, observational cohort study, patients with CKD 4 and 5 or CKD 3 and either accelerated progression and/or proteinuria who are managed in secondary care are eligible to participate. Participants undergo a detailed bio-clinical assessment that includes measures of vascular health, periodontal health, quality of life and socio-economic status, clinical assessment and collection of samples for biomarker analysis. The assessments take place at baseline, and at six, 18, 36, 60 and 120 months; the outcomes of interest include cardiovascular events, progression to end stage kidney disease and death.

Discussion: The determinants of progression of chronic kidney disease are not fully understood though there are a number of proposed risk factors for progression (both traditional and novel). This study will provide a detailed bio-clinical phenotype of patients with high-risk chronic kidney disease (high risk of both progression and cardiovascular events) and will repeatedly assess them over a prolonged follow up period. Recruitment commenced in Autumn 2010 and will provide many outputs that will add to the evidence base for progressive chronic kidney disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of the bio-clinical assessment.
Figure 2
Figure 2
Timeline of study visits and assessments performed.
See this image and copyright information in PMC

References

    1. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375–82. doi: 10.1038/sj.ki.5000058. - DOI - PubMed
    1. Tonelli M, Pfeffer MA. Kidney Disease and Cardiovascular Risk. Annu Rev Med. 2007;58:123–39. doi: 10.1146/annurev.med.58.071105.111123. - DOI - PubMed
    1. O’Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K. Mortality Risk Stratification in Chronic Kidney Disease: One Size for All Ages? J Am Soc Nephrol. 2006;17:846–53. doi: 10.1681/ASN.2005090986. - DOI - PubMed
    1. Stevens PE, O'Donoghue DJ, Lusignan S, Vlymen JV, Klebe B, Middleton R. Chronic kidney disease management in the United Kingdom: {NEOERICA} project results. Kidney Int. 2007;72:92–9. doi: 10.1038/sj.ki.5002273. - DOI - PubMed
    1. De Lusignan S, Chan T, Stevens P, O'Donoghue D, Hague N, Dzregah B. Identifying Patients with Chronic Kidney Disease from General Practice Computer Records. Fam Pract. 2005;22:234–41. doi: 10.1093/fampra/cmi026. - DOI - PubMed